PT - JOURNAL ARTICLE AU - Eliecer, Pereira-Rodríguez Javier AU - Camilo, Quintero-Gomez Juan AU - Otilio, Lopez-Florez AU - Sharon, Waiss-Skvirsky Sandra AU - Ximena, Velásquez-Badillo TI - VENTILATORY SUPPORT IN SARS-VOC-2 DURING INTENSIVE THERAPY AID - 10.1101/2020.05.14.20098608 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.14.20098608 4099 - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20098608.short 4100 - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20098608.full AB - Introduction The SARS-CoV-2 disease outbreak has now become a pandemic. Critical patients with COVID-19 require basic and advanced respiratory support. Therefore, the objective was to describe the ventilatory support strategies in SARS-CoV-2 during intensive therapy.Materials and methods A systematic review of observational studies of the available scientific literature was performed in accordance with the recommendations of the Cochrane collaboration and the criteria of the PRISMA Declaration.Results Fifteen observational studies were included that gave a study population of 4,081 patients. Mechanical ventilation is the main respiratory support treatment for critically ill patients, which should be administered as soon as normal oxygenation cannot be maintained, and despite the fact that there is no current consensus on the parameters of mechanical ventilation, the evidence collected suggests the use of Fio2 on average 50%, PEEP of 14 cmH2O, lung compliance of 29-37 ml per cm of water, driving pressure between 12-14 cm of water and a plateau pressure of 22-25 cm of water.Conclusions IL-6 is shown as a possible marker of respiratory failure and a worse prognosis as well as obesity. In addition, the use of prone position, neuromuscular blockade, pulmonary vasodilators, ECMO, and mechanical ventilation based on the clinical conditions and needs of the patient with COVID-19 are strategies that could benefit patients entering intensive therapy for SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research does not receive any monetary or other funds for its realization.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have all the information presented in this investigation and we leave it at the disposal of the different authors and that they consider important to be able to replicate or, in effect, use it for their investigations.